StockCode
688506
Investors
中文 | EN
中文|EN

Biokin Pharmaceutical Listed on the "2026 Top 100 Chinese Pharmaceutical Industrial Enterprises by Comprehensive Competitiveness"

2026-08-13

On August 11, 2026 Health Industry (International) Ecosystem Conference (CPEO) was grandly held in Boao, Hainan. At the themed dinner entitled "Breath of the Earth", Sinohealth Industry Research Institute officially unveiled the "2026 Top 100 Chinese Pharmaceutical Industrial Enterprises by Comprehensive Competitiveness", with Biokin Pharmaceutical successfully listed thereon.


Centered on three core dimensions, namely "market value/valuation", "commercialization capability" and "R&D capacity", Sinohealth Industry Research Institute constructed a competitiveness index model to evaluate the comprehensive development performance of pharmaceutical industrial enterprises and finalize the list based on the comprehensive competitiveness index. The ranking aims to identify outstanding enterprises with robust comprehensive strength and remarkable contributions to the industry, and advance high-quality, innovation-driven and sustainable development of China’s pharmaceutical industry.


插图.jpg


SystImmune
Baili Pharmaceutical
Guorui Pharmaceutical
Baili-Bio
Jingxi Pharmaceutical
Hiatt Technology
Company Address:1#, Building 1,No.161, Baili Road, Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City
Postcode:610041
Tel:028-85183639
Sichuan Biokin Pharmaceutical Co.,Ltd Copyright © 2018 All rights reserved
SICPB No. 17035664-1   
Internet Drug Information Service Qualification Certificate S/N: (C)-FJYX-2022-0343